The goal of this study  is to understand how we can slow or reverse the emergence of AD symptoms

Contact information for the PREVENT-Alzheimer study

Research team of the PREVENT-Alzherimer Program.  

The goal of the PREVENT-AD program is to study memory and brain changes in healthy people over the age of 60.

To date, there is no known cure for Alzheimer's Disease. Current drug treatments offer modest symptom relief, but none of the medications is known to delay or halt the progression of the disease.

McGill and the Douglas have joined hands to create the StoP-AD Centre dedicated to the prevention of AD.

Alzheimer's disease: A ticking bomb Canada and the world face a ruinous increase in the incidence of dementia caused by Alzheimer’s disease (AD). Around the globe, more than 35 million people have dementia. Their care costs $600 billion each ye

Most anxiety disorders are treated with cognitive-behavioral therapy (CBT), medication, or a combination of the two.

Martin Lepage's team is working on the following neurocognitive and neuroimaging research projects.

StoP-AD Centre has established graduate student and post-doctoral training scholarships.